R
RxREVU
Biotech & Life Sciences · Denver, United States · Founded 2013
Helps patients and providers save money on prescriptions by identifying the most effective medication at the best possible cost MoreLess
RxRevu operates in the healthcare technology sector, focusing on providing real-time prescription benefit data to healthcare providers. The company serves hospitals, health systems, and electronic health record (EHR) vendors across the United States. RxRevu's core product is a price transparency network that delivers patient-specific cost and coverage information at the point of care. This service helps healthcare providers make informed prescribing decisions, ultimately aiming to improve patient outcomes and reduce healthcare costs. The business model revolves around partnerships with healthcare organizations and EHR vendors, generating revenue through subscription fees and data-sharing agreements. By integrating its solution into native EHR workflows, RxRevu ensures that providers have seamless access to critical cost and coverage data during patient consultations. The company has been recognized for its rapid growth and innovation, as evidenced by its inclusion in the Inc. 5000 list of fastest-growing private companies.
Keywords: price transparency, healthcare technology, prescription benefit data, EHR integration, patient-specific information, cost reduction, value-based care, healthcare providers, real-time data, subscription model.
Company overview
RxREVU company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2013
- Headquarters
- Denver, United States
- Employees
- 43
- Open positions
- None listed
- Dealroom signal
- 62.4
- Investment activity
- 1 companies · latest Mar 2026
- Capital deployed
- —
- Preferred round
- MERGER
Valuation & funding
RxREVU funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| MERGER✓Other financing | Mar 2026 | $0 | — | DoseSpot | ↗ |
| LATE VC✓Equity / VC | Jul 2021 | $8M | $80M | JAZZ Venture Partners | — |
| SERIES B✓Equity / VC | Jan 2021 | $7M | $80M | JAZZ Venture Partners | — |
| SERIES A✓Equity / VC | Jun 2019 | $16M | $64M | UnityPoint Health · UCHealth · Presbyterian Healthcare Services · JAZZ Venture Partners | — |
| EARLY VC✓Equity / VC | Jan 2017 | $4.7M | $19M | Undisclosed | — |
| SEED✓Equity / VC | Mar 2016 | Undisclosed | — | ||
| SEED✓Equity / VC | Apr 2015 | Undisclosed | — | ||
| SEED✓Equity / VC | Jul 2014 | Undisclosed | — | ||
| EARLY VC✓Equity / VC | Dec 2013 | Undisclosed | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $9.1M | 0% | 40 |
| 2025 | $9.1M | 0% | 70 |
| 2024 | $9.1M | 0% | 61 |
| 2023 | $9.1M | +4.2% | 69 |
| 2022 | $8.8M | 0% | 78 |
| 2021 | $8.8M | +90.2% | 78 |
| 2020 | $4.6M | — | 54 |
Growth signals
RxREVU website traffic
Latest recorded traffic for RxREVU is 240 monthly website visits, down 87.4% over the last three months. RxREVU's team declined 38.6% over the past year.
Comparisons
RxREVU compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
RxREVU investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
RxREVU's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where RxREVU has talent and traffic
team presence
In the news
Latest news about RxREVU
Recent press, funding announcements, and product moves mentioning RxREVU — open to read from the original sources.
Market sentiment
What the market is saying about RxREVU
An AI-synthesized read of the highest-engagement posts about RxREVU on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See RxREVU’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.





















